Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US. (August 2021)

• Record Type: Journal Article
• Authors: Xue, Qingping; Pan, An; Wen, Ying; Huang, Yichao; Chen, Da; Yang, Chun-Xia; HY Wu, Jason; Yang, Jie; Pan, Jay; Pan, Xiong-Fei
• Is Part Of: Environment international. Volume 153(2021)
• Publication Date: 2021-08
• Subjects: Pyrethroids -- 3-phenoxybenzoic acid -- Cardiovascular disease -- Coronary heart disease -- Stroke; Environmental protection -- Periodicals; Environmental health -- Periodicals; Environmental monitoring -- Periodicals; Environmental Monitoring -- Periodicals; Environnement -- Protection -- Périodiques; Hygiène du milieu -- Périodiques; Environnement -- Surveillance -- Périodiques; Environmental health; Environmental monitoring; Environmental protection; Periodicals; 333.705
• DOI: 10.1016/j.envint.2021.106545
• Languages: English
• ISSNs: 0160-4120

Abstract

Highlights: 3-phenoxybenzoic acid, as an indicator of pyrethroids, was associated adversely associated with cardiovascular disease and stroke in the US adults. The associations seemed to be linear for both cardiovascular disease and stroke. Our findings may highlight the need for routine monitoring of pyrethroids exposure and its health impacts in the population. Abstract: Objective: Pyrethroids-containing products are widely used as commercial and household insecticides. While animal studies and clinical case reports have shown acute cardiovascular outcomes of pyrethroids exposure, little has been known on the effect of chronic pyrethroid exposure on cardiovascular disease (CVD). We aimed to examine the associations between chronic pyrethroid exposure and CVD in the US adults. Methods: Cross-sectional data from the National Health and Nutrition Examination Survey 1999–2002 and 2007–2012 were analyzed. The exposure to pyrethroids was determined as the urinary level of 3-phenoxybenzoic acid (3-PBA), and CVD was ascertained based on self-reported physician diagnoses. Multivariable logistic regression models were fitted to evaluate associations of pyrethroid exposure with CVD, coronary heart disease (CHD), and stroke. Results: Included were 6, 471 participants with a mean age of 44.77 years (standard error, 0.39) for final analyses. The weighted prevalence of CVD, CHD, and stroke was 6.85%, 4.57% and 2.27%, respectively. With adjustments for major confounders, participants in the highest tertile of urinary 3-PBA had higher odds of CVD (odds ratio, 1.58; 95% confidence interval: 1.12, 2.23) and CHD (OR, 1.75; 95% CI: 1.17, 2.61) compared to those in the lowest tertile. There were linear associations for CVD ( P for trend = 0.04) and CHD ( P for trend = 0.02). However, no significant association was noted for stroke (1.29; 0.78, 2.16) in the main analyses. Conclusions: 3-PBA was adversely associated with CVD and CHD in the US adults. Our findings highlight potential cardiovascular risk of chronic exposure to pyrethroids, and should be validated in large prospective studies in different populations in future.